The health and economic impact of dengue in Latin America.
In the last two decades, all countries in the tropical regions of Latin America have experienced marked increases in the incidence of both classic dengue and dengue hemorrhagic fever. Major risk factors for the occurrence of dengue in the region, as well as some regional peculiarities in its clinical expression, such as the extensive involvement of older age groups, have been defined. While little information exists on the economic impact of dengue in the region in terms of disease burden, the estimated loss associated with the disease is on the same order of magnitude as tuberculosis, sexually transmitted diseases (excluding HIV/AIDS), Chagas disease, leishmaniasis, or intestinal helminths. Therefore, similar priority should be given in the allocation of resources for dengue research and control. Data on cost-efficacy and cost-benefit analysis of dengue control programs in Latin America are scarce; however, the cost per DALY averted by control programs during endemic periods appears low, as compared to other mosquito-borne diseases like yellow fever, leishmaniasis, or malaria. Additionally, the cost-benefit ratio of the control programs has proven to be positive.
Torres
Jaime R
JR
Facultad de Medicina, Universidad Central de Venezuela, Caracas 1041-A, Venezuela. torresj@iname.com
Castro
Julio
J
D000330:Aedes; D000818:Animals; D003140:Communicable Disease Control / Q000191:economics; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003715:Dengue / Q000191:economics* / Q000453:epidemiology* / Q000517:prevention & control; D003716:Dengue Virus; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D007303:Insect Vectors; D007843:Latin America / Q000453:epidemiology; D012307:Risk Factors